SUBMISSION COVER SHEET

IMPORTANT: Check box if Confidential Treatment is requested

Registered Entity Identifier Code (optional): 22-350

Organization: Chicago Mercantile Exchange Inc. ("CME")

Filing as a: DCM SEF DCO SDR 

Please note - only ONE choice allowed.

Filing Date (mm/dd/yy): August 12, 2022 Filing Description: Modifications to the PostTrade Fee Schedule for FEX Natural Gas Products

SPECIFY FILING TYPE 

Please note only ONE choice allowed per Submission.

Organization Rules and Rule Amendments

Certification § 40.6(a)

Approval § 40.5(a)

Notification § 40.6(d)

Advance Notice of SIDCO Rule Change § 40.10(a)

SIDCO Emergency Rule Change § 40.10(h)

Rule Numbers: N/A

New Product Please note only ONE product per Submission.

Certification § 40.2(a) 

Certification Security Futures § 41.23(a)

Certification Swap Class § 40.2(d)

Approval § 40.3(a)

Approval Security Futures § 41.23(b)

Novel Derivative Product Notification § 40.12(a)

Swap Submission § 39.5

Official Product Name: 

Product Terms and Conditions (product related Rules and Rule Amendments)

Certification § 40.6(a) 

Certification Made Available to Trade Determination § 40.6(a)

Certification Security Futures § 41.24(a)

Delisting (No Open Interest) § 40.6(a) 

Approval § 40.5(a)

Approval Made Available to Trade Determination § 40.5(a)

Approval Security Futures § 41.24(c)

Approval Amendments to enumerated agricultural products § 40.4(a), § 40.5(a)

“Non-Material Agricultural Rule Change” § 40.4(b)(5)

Notification § 40.6(d)

Official Name(s) of Product(s) Affected: 

Rule Numbers: 
300 Vesey Street New York, NY 10282 T 212 299 2200 F 212 301 4645 christopher.bowen@cmegroup.com cmegroup.com

1

Christopher Bowen 

Managing Director and Chief Regulatory Counsel

Legal Department

August 12, 2022

VIA ELECTRONIC PORTAL

Christopher Kirkpatrick

Office of the Secretariat

Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581

RE: Modifications to the Post-Trade Fee Schedule for FEX Natural Gas Products

CME Submission No. 22-350

Dear Mr. Kirkpatrick:

Chicago Mercantile Exchange Inc. (“CME”), on behalf of its clearing house division (“CME Clearing”), hereby notifies 

the Commodity Futures Trading Commission (“CFTC” or “Commission”) that it is certifying modifications to the posttrade fee schedule applicable contracts it clears on behalf of the FEX Global Marketplace (“FEX”) to reflect the support 

for certain FEX Natural Gas contracts as set out in CME Clearing Advisory 22-238R (the “Fee Schedule”). The Fee 

Schedule will be effective on August 29, 2022.

The Fee Schedule is set forth in Exhibit 1 (attached under separate cover). Modifications appear in Exhibit 1 with 

additions underlined and deletions overstruck.

CME reviewed the derivatives clearing organization (“DCO”) core principles (“Core Principles”) as set forth in the 

Commodity Exchange Act (“CEA”). During the review, CME staff identified the following Core Principles as potentially 

being impacted: 

Financial Resources: The modified fees will not impact CME’s ability to discharge its financial, operational, or 

managerial responsibilities as a DCO.

Public Information: As required by this Core Principle, CME will publish the modified Fee Schedule on the CME Group 

website to ensure that the fees charged by the DCO are publicly available. Execution and related fees established by 

FEX are available on the FEX website. CME provides a link to the FEX fees from the same page where the Fee 

Schedule is published. 

CME certifies that the modifications to the Fee Schedule comply with the CEA and the regulations thereunder. There 

were no substantive opposing views to this proposal. 

CME certifies that this submission has been concurrently posted on the CME Group website at 

http://www.cmegroup.com/market-regulation/rule-filings.html.

If you require any additional information regarding this submission, please e-mail 

CMEGSubmissionInquiry@cmegroup.com or contact the undersigned at (212) 299-2200. Please reference our CME 

Submission No. 22-350 in any related correspondence.

Sincerely,

/s/ Christopher Bowen

Managing Director and Chief Regulatory Counsel

Attachment: Exhibit 1 (attached under separate cover) (blacklined)
2

EXHIBIT 1

FEX Post-Trade Fee Schedule

(attached under separate cover)

(additions underlined; deletions overstruck)